Literature DB >> 27553833

Exportin-5 Functions as an Oncogene and a Potential Therapeutic Target in Colorectal Cancer.

Kunitoshi Shigeyasu1,2, Yoshinaga Okugawa1,3, Shusuke Toden1, C Richard Boland1, Ajay Goel4.   

Abstract

Purpose: Dysregulated expression of miRNAs has emerged as a hallmark feature in human cancers. Exportin-5 (XPO5), a karyopherin family member, is a key protein responsible for transporting precursor miRNAs from the nucleus to the cytoplasm. Although XPO5 is one of the key regulators of miRNA biogenesis, its functional role and potential clinical significance in colorectal cancer remains unclear.Experimental Design: The expression levels of XPO5 were initially assessed in three genomic datasets, followed by determination and validation of the relationship between XPO5 expression and clinicopathologic features in two independent colorectal cancer patient cohorts. A functional characterization of XPO5 in colorectal cancer was examined by targeted gene silencing in colorectal cancer cell lines and a xenograft animal model.
Results: XPO5 is upregulated, both at mRNA and protein levels, in colorectal cancers compared with normal tissues. High XPO5 expression is associated with worse clinicopathologic features and poor survival in colorectal cancer patient cohorts. The siRNA knockdown of XPO5 resulted in reduced cellular proliferation, attenuated invasion, induction of G1-S cell-cycle arrest, and downregulation of key oncogenic miRNAs in colorectal cancer cells. These findings were confirmed in a xenograft animal model, wherein silencing of XPO5 resulted in the attenuation of tumor growth.Conclusions: XPO5 acts like an oncogene in colorectal cancer by regulating the expression of miRNAs and may be a potential therapeutic target in colorectal cancer. Clin Cancer Res; 23(5); 1312-22. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27553833      PMCID: PMC5435115          DOI: 10.1158/1078-0432.CCR-16-1023

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  36 in total

Review 1.  Non-coding RNAs: regulators of disease.

Authors:  Ryan J Taft; Ken C Pang; Timothy R Mercer; Marcel Dinger; John S Mattick
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

Review 2.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

3.  Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.

Authors:  Sonosuke Tanaka; Noboru Hattori; Nobuhisa Ishikawa; Hiroyasu Shoda; Atsushi Takano; Ryohei Nishino; Morihito Okada; Koji Arihiro; Kouki Inai; Hironobu Hamada; Akihito Yokoyama; Nobuoki Kohno
Journal:  Int J Cancer       Date:  2011-04-27       Impact factor: 7.396

4.  Genetic and epigenetic association studies suggest a role of microRNA biogenesis gene exportin-5 (XPO5) in breast tumorigenesis.

Authors:  Derek Leaderer; Aaron E Hoffman; Tongzhang Zheng; Alan Fu; Joanne Weidhaas; Trupti Paranjape; Yong Zhu
Journal:  Int J Mol Epidemiol Genet       Date:  2010-11-25

5.  Novel Evidence for Curcumin and Boswellic Acid-Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer.

Authors:  Shusuke Toden; Yoshinaga Okugawa; Constanze Buhrmann; Durgha Nattamai; Esperanza Anguiano; Nicole Baldwin; Mehdi Shakibaei; C Richard Boland; Ajay Goel
Journal:  Cancer Prev Res (Phila)       Date:  2015-02-23

6.  A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells.

Authors:  Sonia A Melo; Catia Moutinho; Santiago Ropero; George A Calin; Simona Rossi; Riccardo Spizzo; Agustin F Fernandez; Veronica Davalos; Alberto Villanueva; Guillermo Montoya; Hiroyuki Yamamoto; Simo Schwartz; Manel Esteller
Journal:  Cancer Cell       Date:  2010-10-19       Impact factor: 31.743

7.  Downregulation of anti-oncomirs miR-143/145 cluster occurs before APC gene aberration in the development of colorectal tumors.

Authors:  Akemi Kamatani; Yoshihito Nakagawa; Yukihiro Akao; Naoko Maruyama; Mitsuo Nagasaka; Tomoyuki Shibata; Tomomitsu Tahara; Ichiro Hirata
Journal:  Med Mol Morphol       Date:  2013-02-09       Impact factor: 2.309

8.  Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis.

Authors:  Yoshinaga Okugawa; Yuji Toiyama; Keun Hur; Shusuke Toden; Susumu Saigusa; Koji Tanaka; Yasuhiro Inoue; Yasuhiko Mohri; Masato Kusunoki; C Richard Boland; Ajay Goel
Journal:  Carcinogenesis       Date:  2014-10-03       Impact factor: 4.944

9.  Deciphering cellular states of innate tumor drug responses.

Authors:  Esther Graudens; Virginie Boulanger; Cindy Mollard; Régine Mariage-Samson; Xavier Barlet; Guilaine Grémy; Christine Couillault; Malika Lajémi; Dominique Piatier-Tonneau; Patrick Zaborski; Eric Eveno; Charles Auffray; Sandrine Imbeaud
Journal:  Genome Biol       Date:  2006-03-15       Impact factor: 13.583

10.  Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted.

Authors:  S Langbein; M Zerilli; A Zur Hausen; W Staiger; K Rensch-Boschert; N Lukan; J Popa; M P Ternullo; A Steidler; C Weiss; R Grobholz; F Willeke; P Alken; G Stassi; P Schubert; J F Coy
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

View more
  14 in total

Review 1.  Karyopherins in cancer.

Authors:  Tolga Çağatay; Yuh Min Chook
Journal:  Curr Opin Cell Biol       Date:  2018-02-04       Impact factor: 8.382

2.  Upregulation of polycistronic microRNA-143 and microRNA-145 in colonocytes suppresses colitis and inflammation-associated colon cancer.

Authors:  Urszula Dougherty; Reba Mustafi; Hongyan Zhu; Xiaorong Zhu; Dilip Deb; Stephen C Meredith; Fatma Ayaloglu-Butun; Michelle Fletcher; Arantxa Sanchez; Joel Pekow; Zifeng Deng; Nader Amini; Vani J Konda; Vijaya L Rao; Atsushi Sakuraba; Akushika Kwesi; Sonia S Kupfer; Alessandro Fichera; Loren Joseph; John Hart; Fang He; Tong-Chuan He; Diana West-Szymanski; Yan Chun Li; Marc Bissonnette
Journal:  Epigenetics       Date:  2020-12-28       Impact factor: 4.528

3.  Linkage analysis revealed risk loci on 6p21 and 18p11.2-q11.2 in familial colon and rectal cancer, respectively.

Authors:  Susanna von Holst; Xiang Jiao; Wen Liu; Vinaykumar Kontham; Jessada Thutkawkorapin; Jenny Ringdahl; Patrick Bryant; Annika Lindblom
Journal:  Eur J Hum Genet       Date:  2019-04-05       Impact factor: 4.246

4.  MicroRNA Biogenesis Pathway Genes Are Deregulated in Colorectal Cancer.

Authors:  Petra Vychytilova-Faltejskova; Alena Svobodova Kovarikova; Tomas Grolich; Vladimir Prochazka; Katerina Slaba; Tana Machackova; Jana Halamkova; Marek Svoboda; Zdenek Kala; Igor Kiss; Ondrej Slaby
Journal:  Int J Mol Sci       Date:  2019-09-10       Impact factor: 5.923

5.  A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.

Authors:  Zheng Zhu; Yang Lan; Lihong Wang; Jia Ge; Jiao Wang; Feng Liu; Zhicheng He; Hua Zhang; Min Luo; Dandan Lin; Yaoyao Tan; Yuanyuan Xu; Tao Luo
Journal:  BMC Cancer       Date:  2020-11-09       Impact factor: 4.430

6.  LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription.

Authors:  Zhongjie Lin; Shunjie Xia; Yuelong Liang; Lin Ji; Yu Pan; Shi Jiang; Zhe Wan; Liye Tao; Jiang Chen; Chengping Lin; Xiao Liang; Junjie Xu; Xiujun Cai
Journal:  Theranostics       Date:  2020-07-11       Impact factor: 11.556

Review 7.  The Role of Exportin-5 in MicroRNA Biogenesis and Cancer.

Authors:  Ke Wu; Juan He; Wenchen Pu; Yong Peng
Journal:  Genomics Proteomics Bioinformatics       Date:  2018-04-30       Impact factor: 7.691

8.  Evaluating the Oncogenic and Tumor Suppressor Role of XPO5 in Different Tissue Tumor Types

Authors:  Munazza Khan; Zafaruddin Khan; Yaser Uddin; Sadaf Mustafa; Irfan Shaukat; Jianbo Pan; Naseruddin Höti
Journal:  Asian Pac J Cancer Prev       Date:  2018-04-27

9.  Prognostic roles of the transcriptional expression of exportins in hepatocellular carcinoma.

Authors:  Lubiao Chen; Yanlin Huang; Liang Zhou; Yifan Lian; Jialiang Wang; Dongmei Chen; Huan Wei; Mingsheng Huang; Yuehua Huang
Journal:  Biosci Rep       Date:  2019-08-19       Impact factor: 3.840

10.  Uncoupling of gene expression from copy number presents therapeutic opportunities in aneuploid cancers.

Authors:  Vakul Mohanty; Fang Wang; Gordon B Mills; Ken Chen
Journal:  Cell Rep Med       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.